本文观察罗格列酮 (文迪雅 )对初诊肥胖型 2型糖尿病血糖、血脂、血压 ,体重指数及胰岛素敏感性的影响。对 68例初诊轻度肥胖型 2型糖尿病患者在饮食和运动治疗二周的基础上 ,单用文迪雅 4mg/d治疗 12周对治疗前后的血糖、血脂、血压、血清胰岛素及体重指数变化进行比较。结果表明 ,罗格列酮治疗初诊轻度肥胖型 2型糖尿病患者具有降糖、降脂及增加胰岛素敏感性。 This article observes rosiglitazone (Diandia) on newly diagnosed obese type 2 diabetes, blood glucose, blood pressure, body mass index and insulin sensitivity. 68 cases of newly diagnosed mild obesity type 2 diabetes patients on the basis of two weeks of diet and exercise, with Avandin 4mg / d for 12 weeks on the changes of blood glucose, blood lipids, blood pressure, serum insulin and body mass index Compare. The results show that rosiglitazone treatment of newly diagnosed mild obesity type 2 diabetes patients with hypoglycemic, lipid-lowering and increase insulin sensitivity.